Clinical Trial Update: Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating safety, tolerability, and immune response of Tick-borne encephalitis vaccines in healthy children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Drugs mentioned

• Tick-borne encephalitis vaccine (Tick-borne encephalitis vaccine)

Snippet

Sponsor: Novartis | Conditions: Encephalitis, Tick-Borne | Phase 4 | Status: COMPLETED